期刊文献+

白细胞值≤1×109/L的癌症患者预防使用抗菌药物效果分析

Prophylactic use of antibiotics for cancer inpatients with leukocyte count ≤ 1 × 109/L
原文传递
导出
摘要 目的 观察分析放化疗导致白细胞计数≤1×109/L的癌症住院患者应用抗菌药物预防感染的效果,为合理使用抗菌药物提供依据.方法 对2014年426例放化疗导致白细胞计数≤1.0×109/L的癌症住院患者进行回顾性分析,统计抗菌药物预防性使用与患者医院感染获得情况.结果 426例住院患者中,预防性使用抗菌药物的患者感染率为11.0%,未预防性使用抗菌药物的患者感染率为20.9%,差异有统计学意义(x2 =6.815,P=0.009).发生感染的患者,白细胞计数中位值为0.73×109/L,未发生感染的患者为0.77×109/L,差异无统计学意义(Z=-1.257,P=0.209).感染部位以下呼吸道、上呼吸道和胃肠道为主,分别占48%、12%、11%.病原菌检出前5位的细菌依次为肺炎克雷伯菌、阴沟肠杆菌、大肠埃希菌、产气肠杆菌、金黄色葡萄球菌.预防性使用抗菌药物以头孢菌素类为主.结论 放化疗致癌症住院患者白细胞计数≤1×109/L时,给予合理的预防性应用抗菌药物可降低医院感染率. Objective To investigate the infection prevention effect of prophylactic use of antibiotics for cancer inpatients with leukocyte count ≤ 1 × 109/L.Then to provide the basis for rational use of antibiotics.Methods It was retrospectively surveyed that the infection situation and prophylactic usage of antibiotics in the 426 cancer inpatients with leukocyte count ≤ 1 × 109/L caused by radiotherapy and chemotherapy.Results In the 426 inpatients,the infection rates of patients with and without prophylactic use of antibiotics were 11.0% and 20.9% respectively.The difference was statistically significant (x2 =6.815,P =0.009).The leukocyte count median values of patients with and without infection were 0.73 × 109/L and 0.77 × 109/L respectively.The difference had no statistical significance(Z =-1.257,P =0.209).The main infection sites were lower respiratory tract,upper respiratory tract and gastrointestinal tract with infection rates of 48%,12% and 11%,respectively.The top five pathogens were Klebsiella pneumonia,Enterobacter cloacae,Escherichia coli,Enterobacter aerogenes and Staphylococcus aureus.The most use of antibiotics were cephalosporin.Conclusion When the leukocyte counts of cancer inpatients are less than or equal to 1 × 109/L induced by chemotherapy and radiotherapy,reasonable prophylactic use of antibiotics can reduce hospital infection rates.
出处 《国际肿瘤学杂志》 CAS 2016年第2期103-105,共3页 Journal of International Oncology
关键词 肿瘤 细菌感染 白细胞计数 抗菌药 Neoplasms Bacterial infections Leukocyte count Anti-bacterial agents
  • 相关文献

参考文献8

  • 1詹亚杰,赵莹.2402例肿瘤化疗患者医院感染分析及预防措施[J].北华大学学报(自然科学版),2011,12(4):434-437. 被引量:6
  • 2Caggiano V, Weiss RV, Rickert TS, et al. Incidence, cost, and mor- tality of neutropenia hospitalization associated with chemotherapy [ J ]. Cancer, 2005, 103(9): 1916-1924. DOI: 10. 1002/cncr. 20983.
  • 3杨祺,李朝霞,徐婷.肿瘤化疗患者感染病原菌分布及危险因素分析[J].中华医院感染学杂志,2014,24(20):5008-5009. 被引量:5
  • 4Aapro MS, Bohlius J, Cameron DA, et al. 2010 update of EORTC guide- lines for the use of granulocyte-colony stimulating factor to reduce the in- cidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumous [ J ]. Eur J Cancer, 2011, 47(1): 8-32. DOI: lO. 1016/j. ejca. 2010,10. 013.
  • 5张家会,鄢丽霞,吴秀,李晓蓉,周学敏,青玉凤.白血病人化疗后实施保护性隔离预防感染的效果评价[J].现代生物医学进展,2014,14(17):3338-3340. 被引量:4
  • 6Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America[J]. Clin In- feet Dis, 2011, 52(4): 427-431. DOI: 10,1093/eid/eiq147.
  • 7Penack O, Becket C, Buchheidt D, et al. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Dis- eases Working Party of the German Society of Hematology and Medical Ontology (AGIHO)[J]. Ann Hematol, 2014, 93(7): 1083-1095. DOI: 10. 1007/s00277-014-2086-0.
  • 8张锦林,倪美鑫,季屹红,龚光明,沈康.肿瘤专科医院恶性肿瘤患者医院感染的调查分析[J].中华医院感染学杂志,2011,21(7):1334-1336. 被引量:41

二级参考文献37

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部